Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial

BACKGROUND: Renal denervation (RDN), treating resistant hypertension, has, in open trial design, been shown to lower blood pressure (BP) dramatically, but this was primarily with respect to office BP. METHOD: We conducted a SHAM-controlled, double-blind, randomized, single-center trial to establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathiassen, Ole N., Vase, Henrik, Bech, Jesper N., Christensen, Kent L., Buus, Niels H., Schroeder, Anne P., Lederballe, Ole, Rickers, Hans, Kampmann, Ulla, Poulsen, Per L., Hansen, Klavs W., B⊘tker, Hans E., Peters, Christian D., Engholm, Morten, Bertelsen, Jannik B., Lassen, Jens F., Langfeldt, Sten, Andersen, Gratien, Pedersen, Erling B., Kaltoft, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
ORIGINAL PAPERS: Therapeutic aspects
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933576/
https://www.ncbi.nlm.nih.gov/pubmed/27228432
http://dx.doi.org/10.1097/HJH.0000000000000977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933576/
https://www.ncbi.nlm.nih.gov/pubmed/27228432
http://dx.doi.org/10.1097/HJH.0000000000000977

Ejemplares similares